The drug dealer who exploited a beloved television star’s addiction and sold him the ketamine that killed him has been sentenced to 15 years in federal prison, exposing a disturbing Hollywood drug network that preys on the vulnerable while prosecutors reveal she showed no remorse even after her products caused multiple deaths.
Story Snapshot
- Jasveen Sangha, the “Ketamine Queen,” received 15 years for supplying ketamine that killed actor Matthew Perry in October 2023
- Prosecutors highlighted Sangha’s complete lack of remorse, noting she continued dealing drugs after learning her supply caused another death in 2019
- The case exposed a sophisticated drug trafficking operation targeting Hollywood elite, with multiple defendants involved in the supply chain
- Perry’s personal assistant Kenneth Iwamasa faces sentencing on April 22, 2026, for administering the fatal injections
Hollywood Drug Network Exposed
Jasveen Sangha operated a long-running, high-volume drug trafficking enterprise from her North Hollywood residence, marketing herself as an exclusive supplier to Hollywood’s elite. Federal prosecutors documented that Sangha’s operation was not an isolated incident but rather an established criminal business that targeted celebrities and wealthy clients. The 42-year-old dealer supplied at least 51 vials of ketamine to Matthew Perry through a coordinated network of distributors and enablers, demonstrating the organized nature of her criminal activities. This case reveals a darker reality about how predatory dealers systematically exploit individuals struggling with addiction.
Pattern of Death and Zero Remorse
What makes Sangha’s conduct particularly egregious is her documented pattern of callous disregard for human life. In 2019, her ketamine supply caused the death of Cody McLaury, yet prosecutors emphasized she continued dealing drugs without hesitation after learning of that fatality. This demonstrates a level of moral bankruptcy that goes beyond simple criminal enterprise into willful endangerment of lives for profit. When Matthew Perry died in October 2023 from her ketamine, it marked at least the second death directly attributable to her drug operation. Her defense attorneys argued for leniency based on “exemplary behavior” as an inmate, but Judge Sherilyn Peace Garnett sided with prosecutors’ recommendation for the full 15-year sentence.
Network of Enablers and Accountability
The Perry case exposed multiple defendants operating at different levels of the supply chain, illustrating how celebrity drug addiction creates opportunities for various actors to profit. Dr. Salvador Plasencia, a physician who diverted ketamine into the distribution network, received a relatively light 2.5-year sentence in July 2025. Erik Fleming worked with Sangha to distribute the drugs directly to Perry. Most disturbingly, Kenneth Iwamasa, Perry’s live-in personal assistant who administered the fatal injections, faces sentencing on April 22, 2026, with a potential 15-year sentence. This network of suppliers, distributors, and administrators demonstrates how vulnerable individuals with addiction become targets for organized exploitation.
Justice System Sends Clear Message
Judge Garnett’s statement that Sangha would need to show “epic resilience” during her incarceration signals the severity with which the court viewed her crimes. The 15-year federal sentence, plus three years supervised release, represents one of the stiffer penalties for drug dealers in celebrity overdose cases. Sangha has been in federal custody since August 2024, and as the third of five defendants sentenced, her case sets a precedent for holding drug dealers accountable when their products kill users. For families who have lost loved ones to drug overdoses, particularly those involving dealers who show no remorse and continue operating after causing deaths, this sentence represents a measure of justice that acknowledges the human cost of predatory drug trafficking operations.
Sources:
Jasveen Sangha Sentencing in Matthew Perry Ketamine Queen Case – Fox LA
